Aleafia Health Stock Price, News & Analysis

Aleafia Health announced the launch of its innovative CBD Freshly Minted Roll-on under its Noon & Night brand, emphasizing the growing demand for CBD wellness products. CEO Geoffrey Benic highlighted the brand's market leadership and successful product development, achieving record adult-use sales. The roll-on features a blend of essential oils and 200 mg of CBD, designed for easy local application. Additionally, Benic acquired 357,000 common shares, showcasing his confidence in the company's growth and commitment to high-margin product offerings.

Aleafia Health announced the expansion of its dried flower portfolio with four new large format offerings under its Divvy brand. These include 14-gram pouches featuring the THC strain Sour Kush and the new high-potency cultivar Flo, along with 10-gram pre-milled flower options. This launch targets the dried flower and pre-roll market, which accounted for 70% of total legal cannabis sales in Ontario in late 2020. The products will initially be available in Alberta, backed by positive consumer feedback and strong early sales.

Aleafia Health has successfully exported dried cannabis flower to Germany, marking a significant milestone in accessing Europe's mature cannabis market. The company is fulfilling purchase orders to Germany and has secured permits for additional shipments to Australia. CEO Geoffrey Benic highlighted that this new sales channel could provide consistent revenue. The shipment features Aleafia's THC cultivar, Sour Kush, which exceeded quality standards and did not require irradiation, giving it a competitive edge. The European cannabis market is projected to reach $4.7 billion by 2025, with Germany accounting for nearly half.

Aleafia Health, a leader in cannabis wellness, announced that CEO Geoffrey Benic will present at Canaccord Genuity’s Global Cannabis Conference on May 11, 2021, at 11:00 a.m. EDT. Investors can access the live webcast and a subsequent replay via a provided link. Aleafia Health operates Canada’s largest network of medical cannabis clinics and has a diverse portfolio of cannabis products. The company is vertically integrated, with licensed production facilities, including the first large-scale legal outdoor cultivation site in Canada.

Aleafia Health has secured a Health Canada Research Licence for its cannabis product manufacturing centre in Paris, Ontario, enabling human sensory analysis and palatability trials. This regulatory breakthrough complements the company's ongoing innovation strategy in cannabis products. CEO Geoffrey Benic emphasized the importance of product evaluation practices used in the food industry. Aleafia is developing new product formats, including dried flower, edibles, and extracts, aiming for consistent sensory assessments during development.

Aleafia Health, a leader in cannabis wellness, will present at VirtualInvestorConferences.com on April 20 at 11:00 ET. CEO Geoffrey Benic will engage live with investors, allowing real-time questions. The company recently reported a significant 233% quarter-over-quarter increase in cannabis net revenue and a positive adjusted EBITDA of $4.3 million for Q4 2020. Investors can pre-register for the event and access an archived webcast post-event. Aleafia Health operates extensive cannabis health services across Canada and internationally.

Aleafia Health will release its 2021 Q1 results on May 11, 2021, before market opening. A conference call is scheduled for the same day at 8:30 a.m. EDT, hosted by CEO Geoffrey Benic and CFO Benjamin Ferdinand. The call will be accessible via toll-free numbers for participants in the USA/Canada and internationally. Aleafia Health, a licensed Canadian cannabis company, focuses on providing health and wellness products and services, operating medical clinics, and producing cannabis derivatives.

Aleafia Health has launched its innovative cannabis wellness brand, Noon & Night, introducing two new products: Omega CBD Soft Gels and Lavender Fizz CBD bath bombs. The soft gels are noted for their full-spectrum CBD extract, suspended in omega-3 fish oil, marking a first in the Canadian cannabis sector. The bath bombs, made with locally sourced ingredients, are competitively priced. This launch supports Aleafia's expansion into the Canadian adult-use market, aligning with its strategy to cater to health-conscious consumers.

Aleafia Health has launched its new cannabis brand, Divvy, aimed at frequent cannabis consumers who prioritize quality and affordability. Divvy features five products, including pre-rolls and dried flower, leveraging Aleafia's low-cost cultivation methods. The launch supports Aleafia's strategy to penetrate the adult-use market significantly. With pre-rolls and dried flower accounting for 70% of cannabis sales as of December 2020, Aleafia expects to expand Divvy's offerings throughout 2021. This move underscores Aleafia's growing production capacity and commitment to sustainable practices.